The Egyptian Conference on Medical and Pharmaceutical Biotechnology to be held in Cairo in the middle of Dec., in cooperation with the Egyptian Ministry of Health alongside WHO and other Medical stakeholders, will discuss the topic of Covid-19 vaccine production and pharmaceutical technology transfer.
The upcoming conference will address the challenges surrounding African and MENA access to vaccines against COVID-19 as the greatest threat for human beings in African nations in particular.
In this regard, the Ministry of Health highlighted the need for joined-up solutions to eliminate the pandemic, including the important role of WHO’s assistance to support Egypt and other developing countries, while thanking it for its efforts in producing vaccines as well as ramping up vaccine production technologies.
Commenting on this issue, the CEO of Gennecs Holding Limited Dr. Nibal Dahaba said: “Covid-19 vaccine production and pharmaceutical technology transfer had become an urgent priority in the wake of the unprecedented global challenges posed by the Covid-19 pandemic, and providing safe and effective medicines to ensure better health outcomes is one of the WHO’s objectives in a bid to combat the awful virus.”
“In figures on the intake of vaccines in Africa and the MENA have reached nearly 660 million doses,” Dahaba revealed.
“As the resumption of the awful pandemic, the case for a coordinated multilateral response to the crisis is well established, and further attention to localizing the vaccine technology,and expanding access to vaccines for African and MENA countries, and closing the financing gap is urgently needed,” she noted.
Contributed by Ahmed Emam